Clinical Trials Browser

Active not recruiting × Endometrial Neoplasms × Nivolumab × Clear all

NCT03367741 2025-07-28

Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer

Phase 2 Active not recruiting

GynecologicSarcoma

Carcinosarcoma, Endometrial Neoplasms